Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (393)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
50
2025
487
8.280
 Why?
Multiple Sclerosis, Relapsing-Remitting
15
2025
82
3.520
 Why?
Immunologic Factors
13
2025
260
2.390
 Why?
Neurology
10
2018
116
2.150
 Why?
Immunosuppressive Agents
10
2024
837
1.530
 Why?
Neuromyelitis Optica
4
2023
140
1.070
 Why?
Natalizumab
11
2021
41
0.900
 Why?
Recurrence
8
2025
1134
0.850
 Why?
Diagnostic Errors
2
2017
178
0.670
 Why?
Brain
16
2025
2934
0.640
 Why?
Internship and Residency
5
2011
1264
0.610
 Why?
Drug Substitution
2
2019
63
0.610
 Why?
Fingolimod Hydrochloride
5
2020
39
0.600
 Why?
Rituximab
4
2020
210
0.570
 Why?
Data Collection
4
2011
639
0.570
 Why?
Magnetic Resonance Imaging
25
2026
3892
0.560
 Why?
Dementia, Vascular
3
2009
21
0.550
 Why?
Medication Adherence
2
2019
540
0.510
 Why?
Early Medical Intervention
1
2017
62
0.500
 Why?
Early Diagnosis
2
2017
251
0.490
 Why?
Glatiramer Acetate
6
2019
18
0.470
 Why?
Calcinosis
2
2009
234
0.470
 Why?
Humans
88
2026
145140
0.460
 Why?
Drug Monitoring
1
2019
399
0.450
 Why?
Physicians
4
2016
954
0.450
 Why?
Postural Balance
3
2018
244
0.420
 Why?
Antibodies, Monoclonal, Humanized
8
2023
992
0.390
 Why?
Neuroimaging
2
2026
292
0.360
 Why?
Fatigue
3
2018
363
0.360
 Why?
Dimethyl Fumarate
3
2020
12
0.350
 Why?
Immunoglobulin G
4
2023
887
0.340
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
28
0.310
 Why?
Practice Guidelines as Topic
1
2018
1579
0.310
 Why?
Middle Aged
39
2025
36126
0.310
 Why?
Withholding Treatment
2
2021
80
0.300
 Why?
Adult
44
2026
40665
0.300
 Why?
Psychiatry
2
2009
194
0.280
 Why?
Cysts
1
2009
112
0.270
 Why?
Demyelinating Diseases
4
2019
84
0.270
 Why?
HIV Long Terminal Repeat
3
2001
12
0.270
 Why?
Autoantibodies
3
2023
1508
0.260
 Why?
Education, Medical
1
2011
274
0.260
 Why?
Lymphopenia
2
2020
62
0.250
 Why?
Certification
1
2008
119
0.250
 Why?
Education
2
2007
104
0.250
 Why?
Central Nervous System Cysts
1
2006
13
0.250
 Why?
Female
49
2025
78636
0.240
 Why?
Cerebral Arteries
1
2006
59
0.240
 Why?
Clinical Trials as Topic
3
2016
1058
0.240
 Why?
Leukoencephalopathies
1
2026
24
0.240
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
55
0.240
 Why?
Single-Blind Method
3
2023
316
0.230
 Why?
Male
40
2025
72664
0.230
 Why?
Cerebrovascular Disorders
1
2006
104
0.230
 Why?
DNA, Viral
2
1998
355
0.230
 Why?
Drug Industry
2
2016
49
0.220
 Why?
Ethics, Medical
2
2015
90
0.220
 Why?
Societies, Medical
4
2019
898
0.220
 Why?
HIV Seropositivity
2
1998
119
0.220
 Why?
Conflict of Interest
2
2016
54
0.220
 Why?
Treatment Outcome
12
2023
11741
0.210
 Why?
White Matter
1
2026
152
0.210
 Why?
Databases, Factual
3
2016
1488
0.200
 Why?
Double-Blind Method
4
2023
2057
0.200
 Why?
AIDS Dementia Complex
3
2001
52
0.200
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
68
0.190
 Why?
Microglia
2
2024
270
0.190
 Why?
Heart Aneurysm
1
2002
12
0.180
 Why?
Quality of Health Care
2
2017
692
0.170
 Why?
Heart Septal Defects, Atrial
1
2002
58
0.170
 Why?
B-Lymphocytes
5
2023
866
0.170
 Why?
Interferon beta-1a
2
2019
14
0.170
 Why?
Lymphoma
2
2005
233
0.170
 Why?
Education, Medical, Continuing
2
2015
133
0.160
 Why?
Mental Disorders
2
2007
1154
0.160
 Why?
Central Nervous System Neoplasms
2
2005
177
0.160
 Why?
Agammaglobulinemia
1
2020
36
0.160
 Why?
Brain Neoplasms
4
2016
1328
0.160
 Why?
Interferon-gamma
1
2023
784
0.150
 Why?
Serum Sickness
1
2019
4
0.150
 Why?
Indans
1
2019
13
0.150
 Why?
Oxadiazoles
1
2019
37
0.150
 Why?
Neutropenia
1
2020
154
0.150
 Why?
Disease Progression
4
2021
2857
0.150
 Why?
Diagnosis, Differential
4
2023
1506
0.150
 Why?
Referral and Consultation
1
2005
862
0.140
 Why?
Lymphoma, AIDS-Related
1
1998
14
0.140
 Why?
Adjuvants, Immunologic
3
2015
243
0.130
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
261
0.130
 Why?
Salvage Therapy
1
2019
165
0.130
 Why?
Herpesvirus 8, Human
1
1998
67
0.130
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.130
 Why?
Eye Movements
1
2018
94
0.130
 Why?
Physician-Patient Relations
2
2016
587
0.130
 Why?
Educational Measurement
3
2015
324
0.130
 Why?
Sarcoma, Kaposi
1
1998
83
0.130
 Why?
Central Nervous System
2
2005
281
0.130
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
698
0.120
 Why?
Patient Selection
2
2015
733
0.120
 Why?
Herpesvirus 4, Human
1
2018
172
0.120
 Why?
Young Adult
7
2024
14176
0.120
 Why?
Herpesviridae Infections
1
1998
148
0.120
 Why?
Nervous System Diseases
2
2024
286
0.120
 Why?
Suicide, Assisted
1
1997
31
0.120
 Why?
Neurologists
1
2016
23
0.120
 Why?
Costs and Cost Analysis
1
2017
221
0.120
 Why?
Estriol
1
2015
6
0.120
 Why?
Cost-Benefit Analysis
2
2016
640
0.120
 Why?
Aged
9
2024
26096
0.110
 Why?
Corpus Callosum
2
2006
72
0.110
 Why?
Verbal Learning
2
2013
71
0.110
 Why?
Dizziness
2
2018
101
0.110
 Why?
T-Lymphocytes
1
2023
1993
0.110
 Why?
Retrospective Studies
10
2024
17247
0.110
 Why?
Follow-Up Studies
6
2020
5411
0.100
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
155
0.100
 Why?
Trust
1
2016
155
0.100
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
57
0.100
 Why?
Medication Reconciliation
1
2013
32
0.100
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
132
0.100
 Why?
CD40 Antigens
1
2014
90
0.100
 Why?
JC Virus
1
2013
23
0.100
 Why?
Insurance, Health
1
2016
310
0.100
 Why?
Exercise Therapy
1
2018
475
0.100
 Why?
Anti-Inflammatory Agents
2
2006
477
0.090
 Why?
Stroke
1
2002
1270
0.090
 Why?
Sensation Disorders
1
2012
40
0.090
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
20
0.090
 Why?
Population Surveillance
1
2016
484
0.090
 Why?
Memory Disorders
1
2013
197
0.090
 Why?
Immunoglobulin Heavy Chains
3
2007
86
0.090
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.090
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
20
0.090
 Why?
HIV-1
2
2001
906
0.090
 Why?
Optic Nerve
2
2005
67
0.090
 Why?
T-Lymphocyte Subsets
1
2014
417
0.090
 Why?
Glioma
1
2016
429
0.080
 Why?
Gadolinium
4
2018
84
0.080
 Why?
Academies and Institutes
1
2011
61
0.080
 Why?
United States
8
2024
16065
0.080
 Why?
Self-Assessment
1
2011
74
0.080
 Why?
Learning
1
2015
443
0.080
 Why?
Nerve Regeneration
1
2010
58
0.080
 Why?
Fatal Outcome
3
2006
305
0.080
 Why?
Diagnostic Tests, Routine
1
2011
107
0.080
 Why?
Leukocytosis
1
2010
32
0.080
 Why?
Antigens, CD19
3
2007
128
0.080
 Why?
Cranial Nerve Neoplasms
1
1989
8
0.080
 Why?
Hemangioma, Cavernous
1
1989
13
0.080
 Why?
Optic Chiasm
1
1989
19
0.080
 Why?
Exercise Test
1
2012
626
0.080
 Why?
Biomarkers
3
2014
4282
0.080
 Why?
Central Nervous System Infections
1
2010
35
0.080
 Why?
Severity of Illness Index
3
2014
2928
0.070
 Why?
Quality of Life
3
2021
3194
0.070
 Why?
Disease Management
1
2013
651
0.070
 Why?
Guidelines as Topic
1
2011
266
0.070
 Why?
Spinal Cord
3
2023
382
0.070
 Why?
Neuroprotective Agents
1
2009
147
0.070
 Why?
Physical Therapy Modalities
1
2011
335
0.070
 Why?
Hospital-Physician Relations
1
2007
4
0.070
 Why?
Immunoglobulin Variable Region
2
2004
80
0.060
 Why?
Practice Patterns, Physicians'
1
2016
1365
0.060
 Why?
Workload
1
2009
168
0.060
 Why?
Vasculitis, Central Nervous System
1
2006
16
0.060
 Why?
Headache Disorders
1
2006
19
0.060
 Why?
Nerve Fibers, Myelinated
1
2006
47
0.060
 Why?
Neuropsychological Tests
2
2013
1134
0.060
 Why?
CD4-Positive T-Lymphocytes
1
1993
1138
0.060
 Why?
Antibodies, Monoclonal
2
2011
1505
0.060
 Why?
Methylprednisolone
1
2006
59
0.060
 Why?
Medical Records
1
2007
192
0.060
 Why?
Syndrome
2
2023
380
0.060
 Why?
Antibody Formation
1
2007
287
0.060
 Why?
Huntington Disease
1
2007
61
0.060
 Why?
Glial Fibrillary Acidic Protein
1
2006
122
0.060
 Why?
International Classification of Diseases
1
2007
149
0.060
 Why?
Herpes Zoster
1
2010
318
0.060
 Why?
Contrast Media
3
2018
497
0.060
 Why?
Intracranial Hemorrhages
1
2006
106
0.060
 Why?
Aquaporin 4
1
2006
101
0.060
 Why?
DNA Mutational Analysis
1
2006
407
0.060
 Why?
Adolescent
8
2024
22479
0.060
 Why?
Canada
2
2019
429
0.060
 Why?
Health Care Surveys
1
2007
535
0.060
 Why?
Analysis of Variance
3
2015
1300
0.050
 Why?
Patient Compliance
1
2009
587
0.050
 Why?
Neurologic Examination
1
2005
132
0.050
 Why?
Fellowships and Scholarships
1
2009
354
0.050
 Why?
Cognition Disorders
1
2009
539
0.050
 Why?
Teaching
1
2007
236
0.050
 Why?
RNA, Messenger
1
1992
2803
0.050
 Why?
Program Evaluation
1
2009
943
0.050
 Why?
Surveys and Questionnaires
4
2016
6055
0.050
 Why?
Colorado
2
2024
4538
0.050
 Why?
Central Nervous System Diseases
1
2005
74
0.050
 Why?
Affect
1
2007
320
0.050
 Why?
Neutrophils
1
2010
1123
0.050
 Why?
Simvastatin
1
2004
59
0.050
 Why?
Erythrocytes
1
2010
747
0.050
 Why?
Ophthalmoplegia
1
2003
13
0.050
 Why?
Proteoglycans
1
2004
112
0.050
 Why?
Prevalence
2
2024
2855
0.050
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
53
0.050
 Why?
Faculty, Medical
1
2006
301
0.050
 Why?
B-Lymphocyte Subsets
1
2003
76
0.050
 Why?
Cyclophosphamide
1
2003
266
0.050
 Why?
Radiography
1
2005
852
0.050
 Why?
Neurodegenerative Diseases
1
2024
140
0.050
 Why?
Patient Outcome Assessment
1
2023
130
0.040
 Why?
Academic Medical Centers
1
2005
552
0.040
 Why?
Infusions, Intravenous
1
2023
428
0.040
 Why?
Membrane Glycoproteins
1
2004
499
0.040
 Why?
Students, Medical
1
2006
376
0.040
 Why?
Lymphoma, B-Cell
2
2005
137
0.040
 Why?
Induced Pluripotent Stem Cells
1
2024
272
0.040
 Why?
Pain
1
2007
781
0.040
 Why?
CCAAT-Enhancer-Binding Proteins
1
2001
37
0.040
 Why?
Molecular Sequence Data
3
2004
2881
0.040
 Why?
Disability Evaluation
2
2014
310
0.040
 Why?
Single-Cell Analysis
1
2024
361
0.040
 Why?
Anticoagulants
1
2006
748
0.040
 Why?
Antibodies, Antinuclear
1
2001
62
0.040
 Why?
Schools, Medical
1
2002
159
0.040
 Why?
Peptides
3
2013
997
0.040
 Why?
Cross-Sectional Studies
1
2012
5886
0.040
 Why?
Atrophy
1
2021
198
0.040
 Why?
Time Factors
4
2018
7107
0.040
 Why?
Dementia
1
2005
325
0.040
 Why?
Proteasome Endopeptidase Complex
1
2001
155
0.040
 Why?
Clinical Competence
1
2008
1240
0.040
 Why?
Mobility Limitation
1
2020
67
0.040
 Why?
Venous Thrombosis
1
2002
195
0.040
 Why?
Child
5
2016
22670
0.040
 Why?
Interferon-beta
2
2011
92
0.040
 Why?
Lymphocyte Activation
1
2003
1131
0.040
 Why?
Antibodies, Viral
1
2023
673
0.040
 Why?
Maintenance Chemotherapy
1
2019
42
0.040
 Why?
Cell Separation
2
2014
304
0.040
 Why?
Cerebral Infarction
1
1998
47
0.030
 Why?
Induction Chemotherapy
1
2019
87
0.030
 Why?
Lipids
1
2023
706
0.030
 Why?
HIV Seronegativity
1
1998
29
0.030
 Why?
Base Sequence
2
2001
2168
0.030
 Why?
Genes, myc
1
1998
51
0.030
 Why?
Transplantation, Autologous
1
2019
298
0.030
 Why?
Astrocytoma
1
1998
130
0.030
 Why?
In Situ Hybridization
1
2018
318
0.030
 Why?
Gene Library
1
1997
122
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2018
337
0.030
 Why?
Gene Rearrangement
1
1998
155
0.030
 Why?
Risk Assessment
1
2006
3740
0.030
 Why?
Managed Care Programs
1
1997
140
0.030
 Why?
Syndecan-1
2
2007
43
0.030
 Why?
Drug Administration Schedule
1
2018
781
0.030
 Why?
Morals
1
1997
77
0.030
 Why?
Flow Cytometry
2
2014
1159
0.030
 Why?
Breast Neoplasms
1
2008
2380
0.030
 Why?
Viral Load
1
2018
525
0.030
 Why?
Risk Factors
3
2008
10857
0.030
 Why?
Mutation
1
2006
4071
0.030
 Why?
Polymerase Chain Reaction
1
1998
1039
0.030
 Why?
Survival Analysis
1
2018
1371
0.030
 Why?
Sequence Analysis, DNA
1
1997
776
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1415
0.030
 Why?
Child, Preschool
3
2016
11835
0.020
 Why?
Incidence
1
2020
2915
0.020
 Why?
Congresses as Topic
1
2015
223
0.020
 Why?
Propylene Glycols
1
2013
28
0.020
 Why?
Ocular Physiological Phenomena
1
1992
10
0.020
 Why?
HLA-DR Antigens
1
2014
220
0.020
 Why?
Patient Care Team
1
2019
696
0.020
 Why?
Sphingosine
1
2013
45
0.020
 Why?
beta-Galactosidase
1
1992
76
0.020
 Why?
Quality-Adjusted Life Years
1
2013
123
0.020
 Why?
Drug Therapy, Combination
1
2015
1043
0.020
 Why?
Markov Chains
1
2013
129
0.020
 Why?
Mice, Inbred DBA
1
1992
182
0.020
 Why?
Leukocyte Count
1
1993
316
0.020
 Why?
Haplotypes
1
2014
498
0.020
 Why?
Organ Specificity
1
1992
308
0.020
 Why?
Reference Values
1
2013
798
0.020
 Why?
Comparative Effectiveness Research
1
2013
167
0.020
 Why?
Ki-67 Antigen
1
2012
117
0.020
 Why?
CD3 Complex
1
2012
112
0.020
 Why?
Mental Recall
1
2013
217
0.020
 Why?
Thymus Gland
1
1992
311
0.020
 Why?
Intestine, Small
1
1992
167
0.020
 Why?
Mitoxantrone
1
2011
15
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Mice
2
2023
18303
0.020
 Why?
Muscle Stretching Exercises
1
2011
19
0.020
 Why?
Animals
3
2023
37952
0.020
 Why?
Patient Participation
1
2015
437
0.020
 Why?
Clinical Laboratory Techniques
1
2011
96
0.020
 Why?
Depression
2
2011
1537
0.020
 Why?
Amino Acid Sequence
2
2004
2127
0.020
 Why?
Recombinant Fusion Proteins
1
1992
666
0.020
 Why?
Physical Endurance
1
2011
276
0.020
 Why?
Acyclovir
1
2010
97
0.020
 Why?
Spinal Cord Neoplasms
1
1989
41
0.020
 Why?
Cell Count
1
2010
319
0.020
 Why?
Respiratory Function Tests
1
2011
543
0.020
 Why?
History, 19th Century
1
2009
63
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1742
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
58
0.020
 Why?
Aged, 80 and over
2
2016
8318
0.020
 Why?
Injections
1
2009
198
0.020
 Why?
History, 21st Century
1
2009
220
0.020
 Why?
Pilot Projects
2
2004
1889
0.020
 Why?
History, 20th Century
1
2009
327
0.020
 Why?
Autoimmunity
1
2014
932
0.020
 Why?
Gene Expression
1
1992
1474
0.020
 Why?
Electrocardiography
1
2011
664
0.020
 Why?
Mice, Transgenic
1
1992
2185
0.020
 Why?
Health
1
2007
82
0.020
 Why?
Age of Onset
1
2009
554
0.020
 Why?
Memory
1
2009
294
0.020
 Why?
Association Learning
1
2007
70
0.020
 Why?
Walking
1
2011
542
0.020
 Why?
Herpesvirus 3, Human
1
2010
341
0.010
 Why?
Cerebral Ventricles
1
2006
55
0.010
 Why?
CD8-Positive T-Lymphocytes
1
2012
917
0.010
 Why?
Prognosis
2
2006
4310
0.010
 Why?
Motor Skills
1
2007
104
0.010
 Why?
Models, Theoretical
1
2009
556
0.010
 Why?
Phenotype
1
2014
3138
0.010
 Why?
Genetics
1
2005
23
0.010
 Why?
Hypothalamus
1
2006
163
0.010
 Why?
Immunologic Memory
1
2007
368
0.010
 Why?
Neurosciences
1
2005
24
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Social Support
1
2009
645
0.010
 Why?
Anisotropy
1
2004
73
0.010
 Why?
Clinical Protocols
1
2006
280
0.010
 Why?
Hospitalization
1
2015
2458
0.010
 Why?
Image Interpretation, Computer-Assisted
1
2006
288
0.010
 Why?
Immune System
1
2005
177
0.010
 Why?
Internet
1
2009
689
0.010
 Why?
Plasma Cells
1
2004
79
0.010
 Why?
Antiviral Agents
1
2010
767
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
11
0.010
 Why?
Infrared Rays
1
2003
24
0.010
 Why?
Meningitis, Viral
1
2003
20
0.010
 Why?
Videotape Recording
1
2003
37
0.010
 Why?
Saccades
1
2003
46
0.010
 Why?
Antilymphocyte Serum
1
2003
57
0.010
 Why?
Oligoclonal Bands
1
2003
26
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
263
0.010
 Why?
Whole-Body Irradiation
1
2003
74
0.010
 Why?
Astrocytes
1
2005
228
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
130
0.010
 Why?
Immunoglobulins
1
2003
161
0.010
 Why?
Observer Variation
1
2003
356
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
193
0.010
 Why?
Feasibility Studies
1
2006
1109
0.010
 Why?
Mice, Inbred C57BL
1
1992
5972
0.010
 Why?
ATPases Associated with Diverse Cellular Activities
1
2001
9
0.010
 Why?
Age Factors
1
2009
3338
0.010
 Why?
Administration, Oral
1
2004
862
0.010
 Why?
Consensus Sequence
1
2001
73
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2767
0.010
 Why?
Biopsy
1
2005
1079
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
977
0.010
 Why?
Longitudinal Studies
1
2009
2949
0.010
 Why?
Sex Characteristics
1
2007
775
0.010
 Why?
Cytomegalovirus Infections
1
2003
206
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
23
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
56
0.010
 Why?
Gene Expression Regulation, Viral
1
2001
93
0.010
 Why?
Urinary Tract Infections
1
2003
210
0.010
 Why?
Infant
1
2015
10060
0.010
 Why?
Predictive Value of Tests
1
2006
2115
0.010
 Why?
Cohort Studies
1
2011
5988
0.010
 Why?
Acute Disease
1
2003
1035
0.010
 Why?
Research
1
2003
430
0.010
 Why?
Combined Modality Therapy
1
2003
1264
0.010
 Why?
Lung
1
1992
4101
0.010
 Why?
Arachnoid
1
1998
11
0.010
 Why?
Sensitivity and Specificity
1
2003
1995
0.010
 Why?
Monocytes
1
2001
537
0.010
 Why?
Survival Rate
1
2003
2087
0.010
 Why?
Virus Replication
1
2001
519
0.010
 Why?
Models, Biological
1
2005
1763
0.010
 Why?
Binding Sites
1
2001
1309
0.010
 Why?
Case-Control Studies
1
2004
3616
0.010
 Why?
Aging
1
2007
1962
0.010
 Why?
Reproducibility of Results
1
2003
3410
0.010
 Why?
Transcription, Genetic
1
2001
1454
0.010
 Why?
DNA-Binding Proteins
1
2001
1479
0.010
 Why?
Cells, Cultured
1
2001
4142
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (393) concept(s)
_
Co-Authors Expand Description
See all (39) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)